NewsPrivate Equity05/08/2026
General Atlantic leads Expedition Therapeutics Series B
General Atlantic →Expedition Therapeutics closed a Series B led by General Atlantic with RA Capital, Vivo Capital and existing investors. Brett Zbar was designated to join the board. The financing supports clinical development and research.